Health-tech Founder Strategy

Most startup advisors can help you with narrative and pitch strategy. Very few can also tell you whether your clinical validation approach will hold up under investor scrutiny, whether your regulatory pathway is framed correctly, or whether your go-to-market actually makes sense given how Indian hospitals and clinics make purchasing decisions.

This session is built specifically for founders building in healthtech, medtech, digital health, diagnostics, hospital tech, or any business at the intersection of healthcare and technology where the standard startup playbook only gets you halfway.

My background spans dentistry, strategy consulting at Charles River Associates and Health Advances specializing in oncology and rare diseases, and venture capital with a focus on healthcare innovation. I've evaluated healthtech investments, built market opportunity assessments for biopharma clients, and understand both the clinical reality and the investor perspective.

In this session we work through whatever is most pressing but common areas include:

1. Narrative and positioning: how to frame your clinical insight as a competitive moat, not just a feature
2. Clinical validation strategy: what level of evidence do investors in your specific sub-sector expect to see, and what's the minimum viable proof point?
3. Regulatory framing: how to talk about CDSCO, CE marking, or FDA pathways in a way that reassures investors rather than alarming them
4. Market sizing for health: why standard TAM approaches often fail in healthcare and how to frame the opportunity credibly
5. Reimbursement and pricing narrative: particularly for medtech and diagnostics - how to explain willingness to pay in the Indian healthcare context
6. Go-to-market reality check: hospital sales cycles, physician adoption dynamics, and why B2B2C health models need a different pitch than pure B2B SaaS
7. Investor targeting: which India-based funds and angels are actually active in healthtech right now and what their thesis looks like

This session is distinct from a general founder strategy session. If you're building in healthcare, the nuances matter and a generic advisory lens will miss them.